• Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans

Subscribe to Updates

Get the latest finance news and updates directly to your inbox.

Top News

Nvidia CEO: AI Will Change Everyone’s Jobs, Including My Own

July 14, 2025

Charitable Planning After The Big Beautiful Bill (OBBBA) Is Different

July 14, 2025

Walmart’s Anti-Theft Crackdown: Honest Shoppers Lose Out

July 14, 2025
Facebook Twitter Instagram
Trending
  • Nvidia CEO: AI Will Change Everyone’s Jobs, Including My Own
  • Charitable Planning After The Big Beautiful Bill (OBBBA) Is Different
  • Walmart’s Anti-Theft Crackdown: Honest Shoppers Lose Out
  • Is It Worth Your Time to Join a Class Action Lawsuit?
  • 7 Tech Habits That Are Quietly Costing You More Than You Think
  • 8 Popular Savings Tips That Actually Hurt You in the Long Run
  • Why Waiting for Monthly Financial Reports Is Creating Blind Spots and Slowing Your Growth
  • How I Went From Side Hustle to 7 Figures Using These 4 AI Tools (No Tech Skills Needed)
Monday, July 14
Facebook Twitter Instagram
FintechoPro
Subscribe For Alerts
  • Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans
FintechoPro
Home » Eli Lilly hits record high after earnings, Mounjaro hype. Here’s what the pros are saying
News

Eli Lilly hits record high after earnings, Mounjaro hype. Here’s what the pros are saying

News RoomBy News RoomAugust 9, 20230 Views0
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Email Tumblr Telegram

Market Movers rounded up the best reactions from investors and analysts on Eli Lilly . The experts, including Jim Cramer , discussed the drugmaker after it reported second-quarter revenue and earnings Tuesday that beat Wall Street estimates. The company also raised its full-year guidance as quarterly profit soared 85% from the same period last year. Shares of Eli Lilly hit an all-time high during intraday trading, perhaps also getting a boost from a Novo Nordisk trial. The study found Novo Nordisk’s obesity drug Wegovy, which shares some similarities with Lilly’s Mounjaro, cut the risk of heart disease in participants by 20%. Eli Lilly’s stock finished the day about 14.9% higher. LLY is currently held in Cramer’s Charitable Trust portfolio.

Read the full article here

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Articles

RSS Feed Generator, Create RSS feeds from URL

News November 22, 2024

X CEO Linda Yaccarino addresses Musk’s ‘go f—- yourself’ comment to advertisers

News November 30, 2023

67-year-old who left the U.S. for Mexico: I’m happily retired—but I ‘really regret’ doing these 3 things in my 20s

News November 30, 2023

U.S. GDP grew at a 5.2% rate in the third quarter, even stronger than first indicated

News November 29, 2023

Americans are ‘doom spending’ — here’s why that’s a problem

News November 29, 2023

Jim Cramer’s top 10 things to watch in the stock market Tuesday

News November 28, 2023
Add A Comment

Leave A Reply Cancel Reply

Demo
Top News

Charitable Planning After The Big Beautiful Bill (OBBBA) Is Different

July 14, 20250 Views

Walmart’s Anti-Theft Crackdown: Honest Shoppers Lose Out

July 14, 20250 Views

Is It Worth Your Time to Join a Class Action Lawsuit?

July 14, 20250 Views

7 Tech Habits That Are Quietly Costing You More Than You Think

July 14, 20250 Views
Don't Miss

8 Popular Savings Tips That Actually Hurt You in the Long Run

By News RoomJuly 14, 2025

In a world where financial advice is everywhere—TikTok, YouTube, Reddit, even family dinner—it’s easy to…

Why Waiting for Monthly Financial Reports Is Creating Blind Spots and Slowing Your Growth

July 13, 2025

How I Went From Side Hustle to 7 Figures Using These 4 AI Tools (No Tech Skills Needed)

July 13, 2025

Learn Up to 56 Languages for Just $35

July 13, 2025
Facebook Twitter Instagram Pinterest Dribbble
  • Privacy Policy
  • Terms of use
  • Press Release
  • Advertise
  • Contact
© 2025 FintechoPro. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.